Last $55.05 USD
Change Today +0.10 / 0.18%
Volume 6.2M
As of 8:04 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - teva pharmaceutical-sp adr (TEVA)

NameBoard RelationshipsTitleAge
Erez Vigodman 12 RelationshipsChief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee55
Eyal Desheh 26 RelationshipsChief Financial Officer and Group Executive Vice President62
Carlo De Notaristefani Ph.D.8 RelationshipsChief Executive Officer of Global Operations and President of Global Operations56
Yoo Suk Hong No RelationshipsChief Executive Officer of Teva-Handok--
Ichiro Kikushige No RelationshipsChief Executive Officer of Teva Seiyaku Ltd--

Board Members - teva pharmaceutical-sp adr (TEVA)

NameBoard RelationshipsPrimary CompanyAge
Phillip Frost M.D.159 RelationshipsOpko Health, Inc.77
Erez Vigodman 12 RelationshipsTeva Pharmaceutical Industries Limited55
Amir Elstein 42 RelationshipsIsrael Corporation Ltd.58
Ory Slonim 12 RelationshipsTeva Pharmaceutical Industries Limited71
Dan Propper 25 RelationshipsTeva Pharmaceutical Industries Limited73

Executive Committees* - teva pharmaceutical-sp adr (TEVA)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeJoseph Nitzani 12 Relationships4 Executives
Nominating CommitteeDan Propper 25 Relationships6 Executives
Corporate Governance CommitteeDan Propper 25 Relationships6 Executives
Finance CommitteeGalia Maor 31 Relationships4 Executives
View TEVA Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TEVA:US $55.05 USD +0.10

TEVA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $42.97 USD -0.12
AbbVie Inc $54.48 USD +0.43
Baxter International Inc $76.84 USD -0.03
Bristol-Myers Squibb Co $49.32 USD +0.20
Eli Lilly & Co $64.25 USD +0.53
View Industry Companies
 

Industry Analysis

TEVA

Industry Average

Valuation TEVA Industry Range
Price/Earnings 33.7x
Price/Sales 2.3x
Price/Book 2.0x
Price/Cash Flow 37.8x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TEVA PHARMACEUTICAL-SP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.